Visceral Leishmaniasis - Diagnosis and Management Summary
Species: ...
3.9K
Description

Visceral Leishmaniasis - Diagnosis and Management Summary

Species: Leishmania donovani, Leishmania infantum, Leishmania chagasi

Where: South Asia, East Africa, mediterranean, Middle East and Latin America

Pathogenesis: Leishmania invade and replicate within macrophages → Evades innate and cell-mediated immune responses → Neutralization of complement components, Prevent release of superoxide and NO, Suppress induction of antigen-specific CD4+ T helper

Presentation: 

 • Incubation period 2-6 months

 • Fever, Lymphadenopathy, Malaise, Abdominal Pain, Spontaneous abortion, Weight Loss

 • Can cause Hemophagocytic Lymphohistiocytosis

 • Anemia, Neutropenia, Thrombocytopenia

 • ↑LFTs, ↑Bilirubin, ↑BUN/Cr, ↑Hypergammaglobulinemia

Diagnosis: Bone marrow aspiration (histopathology, culture, PCR, K39)

Treatment:

 1) Liposomal Amphotericin B: 3 mg/kg on days 1-5, 14, and 21 for a total of 21 mg/kg

 2) Miltefosine 50 mg PO tid 28 days

 3) Sodium stibogluconate 20 mg/kg/d IV/IM 28-30 days



By @TheIDtrivia



#Visceral #Leishmaniasis #diagnosis #management #treatment #infectiousdiseases #microbiology
Contributed by

Dr. Gerald Diaz
@GeraldMD
Board Certified Internal Medicine Hospitalist, GrepMed Editor in Chief 🇵🇭 🇺🇸 - Sign up for an account to like, bookmark and upload images to contribute to our community platform. Follow us on IG:  https://www.instagram.com/grepmed/ | Twitter: https://twitter.com/grepmeded/
Medical jobs
view all

0 Comments

Related content